4/16
07:31 pm
aort
How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates [Yahoo! Finance]
Medium
Report
How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates [Yahoo! Finance]
4/13
05:58 pm
aort
1 Stock Under $50 to Own for Decades and 2 We Avoid [Yahoo! Finance]
Low
Report
1 Stock Under $50 to Own for Decades and 2 We Avoid [Yahoo! Finance]
4/10
08:43 am
aort
Artivion (AORT) was upgraded by LADENBURG THALM/SH SH from "neutral" to "buy". They now have a $42.00 price target on the stock.
Low
Report
Artivion (AORT) was upgraded by LADENBURG THALM/SH SH from "neutral" to "buy". They now have a $42.00 price target on the stock.
4/8
08:13 pm
aort
Artivion Secures FDA Approval for NEXUS Aortic Arch System [Yahoo! Finance]
Low
Report
Artivion Secures FDA Approval for NEXUS Aortic Arch System [Yahoo! Finance]
4/7
04:58 pm
aort
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know [Yahoo! Finance]
Low
Report
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know [Yahoo! Finance]
4/7
01:45 pm
aort
Artivion (AORT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $58.00 price target on the stock.
Low
Report
Artivion (AORT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $58.00 price target on the stock.
4/7
07:00 am
aort
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
Low
Report
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
4/6
07:48 pm
aort
Why Artivion (AORT) Stock Is Down Today [Yahoo! Finance]
Low
Report
Why Artivion (AORT) Stock Is Down Today [Yahoo! Finance]
4/2
06:22 am
aort
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks [Yahoo! Finance]
Low
Report
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks [Yahoo! Finance]
4/1
09:32 pm
aort
Is It Too Late To Consider Artivion (AORT) After A 161.6% Three Year Rally? [Yahoo! Finance]
Low
Report
Is It Too Late To Consider Artivion (AORT) After A 161.6% Three Year Rally? [Yahoo! Finance]
4/1
08:45 pm
aort
How The Artivion (AORT) Narrative Is Shifting After A Trimmed Target And Steady Fair Value [Yahoo! Finance]
Low
Report
How The Artivion (AORT) Narrative Is Shifting After A Trimmed Target And Steady Fair Value [Yahoo! Finance]
3/31
06:58 am
aort
1 Profitable Stock with Impressive Fundamentals and 2 That Underwhelm [Yahoo! Finance]
Medium
Report
1 Profitable Stock with Impressive Fundamentals and 2 That Underwhelm [Yahoo! Finance]
3/23
05:39 am
aort
3 of Wall Street's Favorite Stocks We Steer Clear Of [Yahoo! Finance]
Low
Report
3 of Wall Street's Favorite Stocks We Steer Clear Of [Yahoo! Finance]
3/9
08:45 pm
aort
Stifel Remains a Buy on Artivion (AROT) [Yahoo! Finance]
Low
Report
Stifel Remains a Buy on Artivion (AROT) [Yahoo! Finance]
3/5
11:13 am
aort
Artivion (AORT) was given a new $55.00 price target by Stifel Nicolaus.
Low
Report
Artivion (AORT) was given a new $55.00 price target by Stifel Nicolaus.
3/3
04:10 pm
aort
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Low
Report
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
2/22
06:00 am
aort
Artivion (NYSE:AORT) was upgraded by analysts at
Weiss Ratings from a "sell (d)" rating to a "hold (c-)" rating.
Low
Report
Artivion (NYSE:AORT) was upgraded by analysts at
Weiss Ratings from a "sell (d)" rating to a "hold (c-)" rating.
2/15
02:13 am
aort
Why Artivion (AORT) Is Down 7.6% After Mixed Q4 Results And 2026 Guidance Above Consensus [Yahoo! Finance]
Low
Report
Why Artivion (AORT) Is Down 7.6% After Mixed Q4 Results And 2026 Guidance Above Consensus [Yahoo! Finance]
2/14
01:51 am
aort
Artivion (AORT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Artivion (AORT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/13
07:02 pm
aort
Artivion Inc (AORT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges [Yahoo! Finance]
Low
Report
Artivion Inc (AORT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges [Yahoo! Finance]
2/13
02:47 pm
aort
Artivion (NYSE:AORT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $51.00 to $48.00. They now have a "buy" rating on the stock.
Medium
Report
Artivion (NYSE:AORT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $51.00 to $48.00. They now have a "buy" rating on the stock.
2/13
12:34 pm
aort
Artivion (AORT) Stock Trades Down, Here Is Why [Yahoo! Finance]
Medium
Report
Artivion (AORT) Stock Trades Down, Here Is Why [Yahoo! Finance]
2/12
11:13 pm
aort
Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/12
11:09 pm
aort
Artivion outlines 2026 revenue growth target of 10% to 14% with strong AMDS and On-X momentum [Seeking Alpha]
Medium
Report
Artivion outlines 2026 revenue growth target of 10% to 14% with strong AMDS and On-X momentum [Seeking Alpha]
2/12
10:16 pm
aort
Artivion Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Artivion Q4 Earnings Call Highlights [Yahoo! Finance]